Micromedex Launches AI Tool, Axtria Secures $240M Investment, and Stanford Unveils CRISPR-GPT - Life AI Weekly #35

Hi there,

Welcome to this week's edition of Life AI Weekly, where we delve into the latest advancements in Healthcare and Life Sciences AI. This week, we explore a range of exciting developments, including Micromedex introducing a new AI search tool designed to assist clinicians in accessing critical information more efficiently. Meanwhile, Health In Tech is enhancing its AI underwriting capabilities to better serve employers, reflecting the growing trend of AI integration in healthcare operations.

In other news, the AI in oncology market is projected to reach $8.86 billion by 2035, highlighting the increasing reliance on AI technologies in cancer treatment and research. Additionally, Sutter Health and Hyro are collaborating to improve patient communication through AI, showcasing the potential of AI to transform patient interactions and healthcare delivery. Stay tuned as we continue to bring you the latest updates and insights from the world of AI in healthcare.

Axtria has secured a $240 million investment from Kedaara Capital to enhance its AI-driven solutions in the life sciences sector. Meanwhile, DaltonTx has raised £4 million in seed funding to advance its AI-enabled drug discovery platforms, aiming to boost pharmaceutical research efficiency.

Variational AI has partnered with Merck to leverage its Enki™ platform for small molecule therapeutics, with potential milestones reaching USD$349 million.
Formation Bio has expanded its leadership team by adding four executives from industry giants like Pfizer and BenevolentAI to bolster its AI-driven drug development initiatives.

Proya Cosmetics has been recognized with the 'IFSCC 2025 Top 10 Papers of Basic Research Award' for their AI-driven anti-aging research, leading to the development of Cellergy pro™. Meanwhile, Ryght AI has launched its advanced clinical research platform on the Microsoft Azure Marketplace, enhancing clinical trial processes with Azure's cloud infrastructure.

Children's Mercy has developed an AI-driven test to expedite rare disease diagnosis in children. Genomenon and Compass Bioinformatics are partnering to enhance genomic diagnostics in the U.S. and Japan. Stanford Medicine has unveiled CRISPR-GPT, an AI tool for gene therapy research. Radiance Technologies is leading a $5.85 million DARPA project on AI-driven biotechnology. CTIBIOTECH received awards for its AI-enhanced bioprinted skin technology at the IFSCC 2025 Congress.

Micromedex has launched an AI-powered search tool to assist clinicians in accessing drug and toxicology information efficiently, enhancing patient care with quick, accurate answers. Meanwhile, Health In Tech announced an upgrade to its Enhanced Do-It-Yourself Benefit System on September 22, 2025, improving underwriting efficiency for mid- and large-employers.